C-MER Medical announces share repurchase, treasury share changes
C-MER Medical Holdings Limited submitted its Next Day Disclosure Return on September 12, 2025, detailing changes in its issued and treasury shares. The company repurchased 250,000 ordinary shares on the Exchange on September 12, 2025, at prices ranging from HK$1.95 to HK$1.97, totaling HK$488,500. These repurchased shares are held as treasury shares.
This repurchase increased the number of treasury shares by 250,000, bringing the closing balance of treasury shares to 10,008,000. Consequently, the number of issued shares (excluding treasury shares) decreased by 250,000 to 1,245,552,870. The total number of issued shares remains 1,255,560,870.
The repurchase represents 0.0201% of the existing number of issued shares (excluding treasury shares) before the event. The company confirmed that the repurchases align with Main Board Rules and were made under a mandate granted on May 19, 2025, authorizing the repurchase of up to 125,556,087 shares.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when C-MER Eye Care Holdings publishes news
Free account required • Unsubscribe anytime